331 filings
Page 2 of 17
8-K
nmcow1t x2qhhox0
4 Aug 23
Fennec Pharmaceuticals Announces Second Quarter 2023
10:57am
8-K
y4mh0z 3ifn7rdq
12 Jun 23
Submission of Matters to a Vote of Security Holders
6:24pm
8-K
rsc1oyw
6 Jun 23
Other Events
5:39pm
8-K
76g1xkajqs6je
4 Apr 23
Other Events
12:32pm
8-K
qeosnfqf uumu0k
31 Jan 23
Fennec Pharmaceuticals Announces PEDMARK® (sodium thiosulfate injection) Receives Orphan Drug Exclusivity from U.S. FDA
1:36pm
8-K
wiuc 5bos2i
25 Jan 23
Other Events
2:07pm
424B3
ef2ets8
15 Dec 22
Prospectus supplement
5:12pm
EFFECT
3xfksd
13 Dec 22
Notice of effectiveness
12:15am
CORRESP
dg2ihsul r8uocp
8 Dec 22
Correspondence with SEC
12:00am
UPLOAD
9sowqtt2gm23gj8 j13f
7 Dec 22
Letter from SEC
12:00am
8-K
8hqkx4cfliz27b4rubj
17 Oct 22
Fennec Pharmaceuticals Announces Commercial Availability of PEDMARK® (sodium thiosulfate injection) in the United States
9:13am
8-K
7vpm75 ddyj
26 Sep 22
Fennec Pharmaceuticals Announces Second Closing of $20 Million Investment
5:03pm
8-K
mjpgn6iqlj75se6
21 Sep 22
Other Events
3:49pm
8-K
qfomvz0mj9iw dwv
22 Aug 22
Fennec Pharmaceuticals Closes First $5 Million Investment
9:00am